There is now scientific proof that we have the potential to use our mind to heal ourselves! Studies of the mind/body connection and of the power of the body's intention to heal itself are revolutionising approaches to healing.
SimplexCalc is a multivariable desktop calculator for Windows. It is small and simple to use but with much power and versatility underneath. It can be used as an enhanced elementary, scientific, financial or expression calculator.
In addition to arithmetic operation, more than hundred built-in constants and functions can also be used in your expression.
SimplexCalc also has the unlimited ability to extend itself by using custom (user-defined) variables. You can add your own variables for SimplexCalc in order to tackle complex problems with ease and fun. Even you can compile formula once and then calculate the result many times with different variable values.
With the brilliant designs and powerful features of SimplexCalc, you can bring spectacular results to your calculating routines.
CompactCalc is an enhanced scientific calculator for Windows with an expression editor. It embodies prime numbers, rational numbers, generic floating-point routines, hyperbolic and transcendental routines. Its underling implementation encompasses the highest precision, sturdiness and multi-functionality. With the brilliant designs and powerful features of CompactCalc, you can bring spectacular results to your calculating routines.
Johnson & Johnson today honors the winners of the 2012 Dr. Paul Janssen Award for Biomedical Research in a ceremony and scientific symposium at the New York Academy of Sciences in New York, NY. Victor Ambros, Ph.D., of the University of Massachusetts Medical School, and Gary Ruvkun, Ph.D., of Massachusetts General Hospital and Harvard Medical School, received the award for their collaborative discovery of microRNAs (miRNAs) as central regulators of gene expression and development, and will share a $100,000 prize.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58019-johnson-and-johnson-jnj-2012-dr-paul-janssen-award-for-biomedical-research
ScienCalc is a convenient and powerful scientific calculator. ScienCalc calculates mathematical expression. It supports the common arithmetic operations (+, -, *, /) and parentheses.
The program contains high-performance arithmetic, trigonometric, hyperbolic and transcendental calculation routines. All the function routines therein map directly to Intel 80387 FPU floating-point machine instructions.
Scientific calculator gives students, teachers, scientists and engineers the power to find values for even the most complex equation set. You can build equation set, which can include a wide array of linear and nonlinear models for any application.
*Linear equations
*Polynomial and rational equations
*Nonlinear exponential, logarithmic and power equations
*Pre-defined mathematical and physical constants
Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that data from two Phase 2 trials with SAR236553/REGN727, an investigational, high-affinity, subcutaneously administered, fully-human antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9), were presented at the American College of Cardiology’s (ACC) 61st Annual Scientific Meeting in Chicago.
The data showed that treatment with SAR236553/REGN727 over 8 to 12 weeks significantly reduced mean low-density lipoprotein-cholesterol (LDL-C, or “bad” cholesterol) by 40% to 72% in patients with elevated LDL-C on stable dose of statins.
To view Multimedia News Release, go to http://www.multivu.com/mnr/55299-sanofi-regeneron-pharmaceuticals-lipid-lowering-medications-pcsk9-antibody
New findings from the St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project (PCGP) have helped identify the mechanism that makes the childhood eye tumor retinoblastoma so aggressive. The discovery explains why the tumor develops so rapidly while other cancers can take years or even decades to form.
The finding also led investigators to a new treatment target and possible therapy for the rare childhood tumor of the retina, the light-sensing tissue at the back of the eye. The study appears in the January 11 advance online edition of the scientific journal Nature.
To view Multimedia News Release, go to http://www.multivu.com/mnr/46767-st-jude-genome-project-treatment-childhood-eye-tumor-retinoblastoma
To speed progress against cancer and other diseases, the St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project today announced the largest-ever release of comprehensive human cancer genome data for free access by the global scientific community. The amount of information released more than doubles the volume of high-coverage, whole genome data currently available from all human genome sources combined. This information is valuable not just to cancer researchers, but also to scientists studying almost any disease.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52993-st-jude-childrens-research-hospital-comprehensive-human-cancer-genome-data
As part of its charitable giving program, jcp cares, jcpenney is supporting The Breast Cancer Research Foundation, an organization committed to funding scientific research to achieve prevention and a cure for breast cancer in our lifetime. This October, in honor of breast cancer awareness month, jcpenney customers can round up their store purchases to the nearest whole dollar and donate the difference to The Breast Cancer Research Foundation.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54268-jcpenney-invites-customers-to-support-breast-cancer-research-foundation
Millions of young people across the nation will become scientists for the day tomorrow, during the fifth annual 4-H National Youth Science Day (NYSD). This annual event seeks to spark an early youth interest in science education and future careers, and to reclaim the nation’s position of leadership in scientific exploration. As part of 4-H NYSD, youth will participate in the 4-H Eco-Bot Challenge: the 2012 National Science Experiment at hundreds of local events taking place in all 50 states. (See our online event map for time and location information).
To view Multimedia News Release, go to http://www.multivu.com/mnr/58326-4-h-national-youth-science-day-nysd-eco-bot-challenge
Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management solutions, has announced the availability of an extensive set of advanced predictive sciences applications and services. These integrated capabilities enable drug discovery teams to investigate and evaluate hypotheses about the chemical or biological behavior of molecules of therapeutic interest in silico prior to costly experimentation. Accelrys predictive sciences leverages the open, scientifically aware Accelrys Enterprise Platform to deliver an advanced scientific decision support environment that reduces time and expense, improves quality, enhances collaboration and accelerates innovation in bringing new drugs to market.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62190-accelrys-offers-integrated-predictive-sciences-solutions-faster-innovation
Investment in basic research, convergence across disciplines and better engagement between academia and industry are key to the future of innovation, according to a panel of renowned thought leaders speaking at the celebration of the 2013 Dr. Paul Janssen Award for Biomedical Research.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63340-johnson-and-johnson-dr-paul-janssen-global-innovation-thermosensation
